Molecular Prognostic Factors in Adenocarcinoma of the Esophagus and Gastroesophageal Junction

By Lagarde S.   ten Kate F.   Richel D.   Offerhaus G.   van Lanschot J.  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 977-991

Springer Publishing Company

Access to resources Recommend Favorite

p53 Gene Mutations in Sporadic Colorectal Carcinoma in Guangxi Region

By Gao Feng   Li Chensheng   Li Wei   Chen Lisheng   Tang Zongjiang   Tang Weizhong  

Cancer Investigation, Vol. 24, Iss. 7, 2006-09 ,pp. : 689-695

Informa Healthcare

Access to resources Recommend Favorite

p53 Gene Mutations and p21 Protein Expression Induced Independently of p53, by TGF- and -rays in Squamous Cell Carcinoma Cells

By Yoneda K.   Yokoyama T.   Yamamoto T.   Hatabe T.   Osaki T.  

European Journal of Cancer, Vol. 35, Iss. 2, 1999-02 ,pp. : 278-283

Elsevier

Access to resources Recommend Favorite

Tumors of the gastroesophageal junction have intermediate prognosis compared to tumors of the esophagus and stomach, but share the same clinical determinants

By                

Oncology Letters, Vol. 2, Iss. 3, 2011-01 ,pp. : 503-507

Spandidos Publications

Access to resources Recommend Favorite

A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia

By Jatoi Aminah   Tirona Marisa   Cha Steven   Alberts Steven   Rowland Kendrith   Morton Roscoe   Nair Suresh   Kardinal Carl   Stella Philip   Mailliard James   Sargent Daniel   Goldberg Richard  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 2-3, 2002-12 ,pp. : 115-123

Humana Press, Inc

Access to resources Recommend Favorite